BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33689290)

  • 1. Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat Models.
    McMurray L; Macdonald JA; Ramakrishnan NK; Zhao Y; Williamson DW; Tietz O; Zhou X; Kealey S; Fagan SG; Smolek T; Cubinkova V; Žilka N; Spillantini MG; Tolkovsky AM; Goedert M; Aigbirhio FI
    ACS Chem Neurosci; 2021 Jun; 12(11):1885-1893. PubMed ID: 33689290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Of rodents and men: the mysterious interneuronal pilgrimage of misfolded protein tau in Alzheimer’s disease.
    Levarska L; Zilka N; Jadhav S; Neradil P; Novak M
    J Alzheimers Dis; 2013; 37(3):569-77. PubMed ID: 23948940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Bioevaluation of 2-Styrylquinoxaline Derivatives as Tau-PET Tracers.
    Wu N; Zhang L; Zhang X; Zhang Q; Liu J; Li Y; Yan XX; Liang Y; Zhang J; Cui M
    Mol Pharm; 2023 Nov; 20(11):5865-5876. PubMed ID: 37852240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
    J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coevolution of Atomic Resolution and Whole-Brain Imaging for Tau Neurofibrillary Tangles.
    Dalton RM; Krishnan HS; Parker VS; Catanese MC; Hooker JM
    ACS Chem Neurosci; 2020 Sep; 11(17):2513-2522. PubMed ID: 32786315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.
    Maruyama M; Shimada H; Suhara T; Shinotoh H; Ji B; Maeda J; Zhang MR; Trojanowski JQ; Lee VM; Ono M; Masamoto K; Takano H; Sahara N; Iwata N; Okamura N; Furumoto S; Kudo Y; Chang Q; Saido TC; Takashima A; Lewis J; Jang MK; Aoki I; Ito H; Higuchi M
    Neuron; 2013 Sep; 79(6):1094-108. PubMed ID: 24050400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies.
    Olešová D; Dobešová D; Majerová P; Brumarová R; Kvasnička A; Kouřil Š; Stevens E; Hanes J; Fialová Ľ; Michalicová A; Piešťanský J; Šinský J; Kaňovský P; Friedecký D; Kováč A
    J Neuroinflammation; 2024 Mar; 21(1):78. PubMed ID: 38539208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection.
    Fawaz MV; Brooks AF; Rodnick ME; Carpenter GM; Shao X; Desmond TJ; Sherman P; Quesada CA; Hockley BG; Kilbourn MR; Albin RL; Frey KA; Scott PJ
    ACS Chem Neurosci; 2014 Aug; 5(8):718-30. PubMed ID: 24896980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
    Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
    Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils.
    Kuang G; Murugan NA; Zhou Y; Nordberg A; Ågren H
    ACS Chem Neurosci; 2020 Mar; 11(6):900-908. PubMed ID: 32069017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
    Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
    J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models.
    Brendel M; Jaworska A; Probst F; Overhoff F; Korzhova V; Lindner S; Carlsen J; Bartenstein P; Harada R; Kudo Y; Haass C; Van Leuven F; Okamura N; Herms J; Rominger A
    J Nucl Med; 2016 May; 57(5):792-8. PubMed ID: 26912432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluent molecular mixing of Tau isoforms in Alzheimer's disease neurofibrillary tangles.
    Dregni AJ; Duan P; Xu H; Changolkar L; El Mammeri N; Lee VM; Hong M
    Nat Commun; 2022 May; 13(1):2967. PubMed ID: 35624093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.
    Smolek T; Jadhav S; Brezovakova V; Cubinkova V; Valachova B; Novak P; Zilka N
    Mol Neurobiol; 2019 Jan; 56(1):621-631. PubMed ID: 29770957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.
    Uchihara T; Hara M; Nakamura A; Hirokawa K
    Histochem Cell Biol; 2012 Feb; 137(2):261-7. PubMed ID: 22116524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents.
    Zhou K; Yang F; Li Y; Chen Y; Zhang X; Zhang J; Wang J; Dai J; Cai L; Cui M
    Mol Pharm; 2021 Mar; 18(3):1176-1195. PubMed ID: 33475377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.